DYN
Dyne Therapeutics Inc
15.20$
-3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 99.4% | 246.1% | 324.4% | 297.0% | 273.9% | 73.7% | 432.6% | 376.2% | 432.4% | 150.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 15.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.6% | -146.1% | -224.4% | -197.0% | -173.9% | 26.3% | -332.6% | -276.2% | -332.4% | -50.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 85.0% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,553.4% | – | – | – | 5,203.9% | – | – | – | – | – | – | – | |
| 4.6% | 15.7% | 22.0% | 23.5% | 17.0% | 5.6% | 22.9% | 23.2% | 24.2% | 13.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 233.5% | – | – | – | 973.5% | – | – | – | – | – | – | – | |
| 4.6% | 15.7% | 22.0% | 23.5% | 17.0% | 5.6% | 22.9% | 23.2% | 24.2% | 13.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,786.9% | – | – | – | 6,177.4% | – | – | – | – | – | – | – | |
| 17.1% | -6.0% | 86.3% | -332.5% | -48.5% | 4.3% | -28.0% | 11.0% | 31.9% | -99.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,786.9% | – | – | – | -6,177.4% | – | – | – | – | – | – | – | |
| 23.2% | 61.3% | 84.5% | 84.9% | 68.9% | 22.3% | 95.4% | 87.8% | 83.5% | 29.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 44.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.6% | -62.2% | 3.6% | -479.5% | -103.7% | -29.5% | 161.7% | -172.4% | -73.6% | -239.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,759.2% | – | – | – | -5,696.1% | – | – | – | – | – | – | – | |
| 4.5% | -218.0% | 9.5% | 4.2% | -0.4% | 0.8% | -178.9% | -8.8% | -0.5% | -70.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 114.2% | – | – | – | – | – | – | – | – | – | – | – | |
| -3.8% | -61.8% | -6.0% | -483.7% | -103.3% | -23.0% | 341.1% | -163.5% | -73.1% | -300.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,759.2% | – | – | – | -5,696.1% | – | – | – | – | – | – | – | |
| 50.2% | -117.5% | 204.2% | -299.4% | 41.1% | 27.6% | 747.4% | 57.5% | 123.1% | -297.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,748.7% | – | – | – | -5,667.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.